PAI-1 is involved in acquired resistance to osimertinib in EGFR mutated lung cancer thorough its association with EMT
PAI-1 is involved in acquired resistance to osimertinib in EGFR mutated lung cancer thorough its association with EMT
复制标题
PAI-1 通过与 EMT 的关联参与 EGFR 突变肺癌对奥西替尼的获得性耐药
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Noboru Hattori
中科院分区：
文献类型：
--
作者：
Kentaro Tokumo;Takeshi Masuda;Shinjiro Sakamoto;Kazunori Fujitaka;Hironobu Hamada;Noboru Hattori
